anti-BRCA2 and CDKN1A Interacting Protein (BCCIP) Antibodies

BCCIP product was isolated on the basis of its interaction with BRCA2 and p21 proteins. Additionally we are shipping BCCIP Proteins (9) and BCCIP Kits (3) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
BCCIP 56647 Q9P287
BCCIP 66165 Q9CWI3
BCCIP 361666  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-BCCIP Antibodies at antibodies-online.com

Showing 10 out of 47 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Mouse Un-conjugated IF, WB Western blot analysis of TOK-1 on a HeLa cell lysate (Human cervical epitheloid carcinoma, ATCC CCL-2). Lane 1: 1:1000, lane 2: 1:2000, lane 3: 1:4000 dilution of the Mouse Anti-TOK-1 antibody. Immunofluorescence staining of HeLa cells. 50 μg Log in to see 6 to 8 Days
$220.08
Details
Human Rabbit Un-conjugated IHC, WB Western blot analysis of extracts of various cells, using BCCIP antibody. Immunohistochemistry of paraffin-embedded human gastric cancer using BCCIP antibody at dilution of 1:100 (x40 lens). 100 μL Log in to see 16 Days
$323.13
Details
Human Rabbit Un-conjugated ICC, IF, IHC, IHC (p), WB Western Blot: BCCIP Antibody [NBP1-31319] - Sample (30 ug of whole cell lysate) A: A431 B: Hela 10% SDS PAGE; antibody diluted at 1:1000. Immunocytochemistry/Immunofluorescence: BCCIP Antibody [NBP1-31319] - Paraformaldehyde-fixed HeLa, using antibody at 1:200 dilution. 100 μL Log in to see 7 to 9 Days
$447.56
Details
Human Rabbit Un-conjugated ICC, IF, IHC (p), IP, IHC, WB 0.1 mL Log in to see 7 to 9 Days
$486.94
Details
Human Rabbit Un-conjugated IHC (p), IP, IHC Immunohistochemistry: BCCIP Antibody [NBP1-22994] - FPE section of human colon carcinoma. Antibody used at a dilution of 1:250. Detection: DAB staining using Immunohistochemistry Accessory Kit. 100 μL Log in to see 7 to 9 Days
$486.94
Details
Human Mouse Un-conjugated DB 50 μg Log in to see 6 to 8 Days
$285.71
Details
Human Rabbit Alexa Fluor 594 IF (p)   100 μL Log in to see 14 to 21 Days
$405.90
Details
Human Rabbit Alexa Fluor 350 IF (p)   100 μL Log in to see 14 to 21 Days
$405.90
Details
Human Rabbit Cy7 IF (p)   100 μL Log in to see 14 to 21 Days
$405.90
Details
Human Rabbit Cy5.5 IF (p)   100 μL Log in to see 14 to 21 Days
$405.90
Details

BCCIP Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
,
,
, , , , , , , , , , , , ,
Mouse (Murine) ,


, , , , , , , , , , , , ,
Rat (Rattus) ,


, , , , , , , , , , , , ,

Top referenced anti-BCCIP Antibodies

  1. Human Monoclonal BCCIP Primary Antibody for IF, WB - ABIN968821 : Liu, Yuan, Huan, Shen: Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. in Oncogene 2001 (PubMed)
    Show all 2 Pubmed References

More Antibodies against BCCIP Interaction Partners

Human BRCA2 and CDKN1A Interacting Protein (BCCIP) interaction partners

  1. this study identifies BCCIP as a novel factor critical for microtubule regulation and explicates a mechanism utilized by BCCIP in tumor suppression.

  2. Expression of BCCIP beta was notably higher in tumor tissues of esophageal squamous cell carcinoma (ESCC) and Eca 109 cells. In vitro studies such as starvation and refeeding assay along with BCCIP beta-shRNA transfection assay demonstrated that BCCIP beta expression promoted proliferation of ESCC cells.

  3. we demonstrate that BCCIPbeta induces a conformational change within the RAD51 (show RAD51 Antibodies) filament that promotes release of ADP to help maintain an active presynaptic filament. Our findings reveal a functional role for BCCIPbeta as a RAD51 (show RAD51 Antibodies) accessory factor in HR.

  4. the existence of both INO80 (show INO80 Antibodies) and YY1 (show YY1 Antibodies) is required for recruiting the INO80 (show INO80 Antibodies)/YY1 (show YY1 Antibodies) complex to BCCIP promoter region. Our findings strongly indicate that BCCIP is a potential target gene of the INO80 (show INO80 Antibodies)/YY1 (show YY1 Antibodies) complex.

  5. The BCCIPbeta, but not BCCIPalpha, interacts with EIF6 (show EIF6 Antibodies) and RPL23 (show RPL17 Antibodies)/UL14 and stabilizes the latter.

  6. Results indicate that BCCIP germ line mutations are unlikely to be a major contributor to familial breast/ovarian cancer risk in our population.

  7. In BRCA2 (show BRCA2 Antibodies), two novel frame shift mutations were identified as 5073-5074delCT and 6866delC.

  8. BRCA2 (show BRCA2 Antibodies) germline mutations appear to have a milder clinical phenotype when compared to non-BRCA2 (show BRCA2 Antibodies) mutations, since survival is higher among breast cancer patients carrying a BRCA2 (show BRCA2 Antibodies) mutation compared to sporadic breast cancers.

  9. Unique de novo mutation of BRCA2 (show BRCA2 Antibodies) has been identified in a woman with early onset breast cancer.

  10. Overexpression of BCCIP beta delays the G1 to S progression and results in an elevated p21 (show CDKN1A Antibodies) expression

Mouse (Murine) BRCA2 and CDKN1A Interacting Protein (BCCIP) interaction partners

  1. BCCIP represents a paradoxical class of modulators for tumorigenesis as a suppressor for initiation but a requisite for progression.

  2. BCCIP and its anti-replication stress functions are essential for normal neural development by maintaining an orderly proliferation of neural progenitors.

  3. these data suggest a unique function of BCCIP, not only in repair of DNA damage, but also in resolving stalled replication forks and prevention of replication stress

BCCIP Antigen Profile

Protein Summary

This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene.

Gene names and symbols associated with BCCIP

  • BRCA2 and CDKN1A interacting protein (BCCIP) antibody
  • BRCA2 and CDKN1A interacting protein (bccip) antibody
  • BRCA2 and CDKN1A interacting protein (Bccip) antibody
  • 1110013J05Rik antibody
  • BCCIP antibody
  • DKFZp459K2416 antibody
  • MGC82792 antibody
  • MGC89311 antibody
  • mp:zf637-1-000774 antibody
  • TOK-1 antibody
  • TOK1 antibody
  • zgc:110272 antibody

Protein level used designations for BCCIP

BRCA2 and CDKN1A interacting protein , protein BCCIP homolog , BRCA2 and CDKN1A-interacting protein , bccip-like , BCCIPalpha , BCCIPbeta , BRCA2 and Cip1/p21 interacting protein , TOK-1alpha , TOK-1beta , cdk inhibitor p21 binding protein , p21- and CDK-associated protein 1 , protein TOK-1

GENE ID SPECIES
426225 Gallus gallus
541348 Danio rerio
738638 Pan troglodytes
100173923 Pongo abelii
100528563 Ictalurus punctatus
444344 Xenopus laevis
448392 Xenopus (Silurana) tropicalis
56647 Homo sapiens
66165 Mus musculus
512466 Bos taurus
477864 Canis lupus familiaris
100157478 Sus scrofa
361666 Rattus norvegicus
Selected quality suppliers for anti-BCCIP (BCCIP) Antibodies
Did you look for something else?